Abstract
Tubular development continues after birth in full and pre-term infants. As the survival of premature infants increases, serious imbalances in water and electrolytes in this group have become more prevalent. A diminished ability of the immature kidney to reabsorb water and respond to mineralocorticoids, a high excretion of filtered sodium, perinatal complications affecting tubular function, and the use of medications such as diuretics, indomethacin and amphotericin B, are common factors leading to sodium and potassium imbalances in this age group. Appropriate diagnosis and treatment should be guided by a careful assessment of volume status, urine electrolytes and osmolality.
Keywords: Tubular, development, water, sodium, potassium.
Current Pediatric Reviews
Title:Fluid and Electrolyte Disorders in the Newborn: Sodium and Potassium
Volume: 10 Issue: 2
Author(s): Marta Suarez-Rivera and Melvin Bonilla-Felix
Affiliation:
Keywords: Tubular, development, water, sodium, potassium.
Abstract: Tubular development continues after birth in full and pre-term infants. As the survival of premature infants increases, serious imbalances in water and electrolytes in this group have become more prevalent. A diminished ability of the immature kidney to reabsorb water and respond to mineralocorticoids, a high excretion of filtered sodium, perinatal complications affecting tubular function, and the use of medications such as diuretics, indomethacin and amphotericin B, are common factors leading to sodium and potassium imbalances in this age group. Appropriate diagnosis and treatment should be guided by a careful assessment of volume status, urine electrolytes and osmolality.
Export Options
About this article
Cite this article as:
Suarez-Rivera Marta and Bonilla-Felix Melvin, Fluid and Electrolyte Disorders in the Newborn: Sodium and Potassium, Current Pediatric Reviews 2014; 10 (2) . https://dx.doi.org/10.2174/157339631002140513102053
DOI https://dx.doi.org/10.2174/157339631002140513102053 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neutrophil Function in Severe Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeting CFTR: How to Treat Cystic Fibrosis by CFTR-Repairing Therapies
Current Drug Targets What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Current Molecular Medicine Pleiotropic Effects of Drugs Inhibiting the Renin-Angiotensin-Aldosterone System
Current Pharmaceutical Design Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Current Pharmaceutical Biotechnology Role of the Renin-Angiotensin-Aldosterone System in the Pathogenesis of Atherosclerosis
Current Pharmaceutical Design Oxidative-Nitrosative Stress In Hypertension
Current Vascular Pharmacology Nebivolol: More Than a Highly Selective Beta Blocker
Recent Patents on Cardiovascular Drug Discovery Paliperidone Use in the Elderly
Current Drug Safety The Blockade of Renin-Angiotensin-Aldosterone System in Hemodialysis Patients to Control Hypertension and Prevent Cardiovascular Disease: Optimal Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Dual COX-Inhibitors: The Answer is NO?
Current Topics in Medicinal Chemistry Intradialytic Hypertension: An Under-recognized Cardiovascular Risk Factor. What is the Evidence?
Current Hypertension Reviews Targeting <i>Plasmodium Metabolism</i> to Improve Antimalarial Drug Design
Current Protein & Peptide Science Traditional and Alternative Therapies for Refractory Angina
Current Pharmaceutical Design Hydrolyzates of Silkworm Pupae (Bombyx Mori) Protein is a New Source of Angiotensin I-Converting Enzyme Inhibitory Peptides(ACEIP)
Current Pharmaceutical Biotechnology Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation
Current Drug Targets - CNS & Neurological Disorders Cardiotonic Steroids in Adaptation to Dietary Salt Intake
Current Clinical Pharmacology Effects of Onion Extract on Endogenous Vascular H2S and Adrenomedulin in Rat Atherosclerosis
Current Pharmaceutical Biotechnology Cardio-Vascular Risks Associated with Clozapine Treatment
Current Psychiatry Reviews